Article Details

Sweden's EnginZyme bags €21M to commercialise its cell-free biomanufacturing tech

Retrieved on: 2022-12-20 10:12:21

Tags for this article:

Click the tags to see associated articles and topics

Sweden's EnginZyme bags €21M to commercialise its cell-free biomanufacturing tech. View article details on hiswai:

Excerpt

The investment came from new investors Almi Invest GreenTech, Navigare Ventures and Bunge Ventures. Existing investors Sofinnova Partners, ...

Article found on: siliconcanals.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up